Hygeia Chemicals Ltd -v- Irish Medicines Board [2010] IESC 4 (27 January 2010)

Hygeia Chemicals Ltd -v- Irish Medicines Board [2010] IESC 4 (27 January 2010)

The Supreme Court held that the absence of clear by-laws or rules governing the review and appeal process, the lack of transparency regarding the applicable standards, and the imposition of restrictive time limits without adequate disclosure of relevant materials resulted in procedures that did not meet the requirements of constitutional justice and fair procedures. The process adopted by the Irish Medicines Board was found to be unfair and insufficient in law to justify the annulment of valuable property rights.

Citation
[2010] IESC 4
Parties
Applicant/appellant: Hygeia Chemicals Limited; Respondent/respondents: Irish Medicines Board
Jurisdiction
Ireland
Judgment Date
27 January 2010
Procedural Posture
Judicial Review Appeal / Supreme Court Appeal From High Court Judgment
Outcome
Appeal allowed; High Court order set aside.
Legal Topics
Fair Procedures, Natural Justice, Bias, Precautionary Principle, Licensing of Veterinary Medicinal Products, Property Rights, Judicial Review

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 9 Party arguments 2
Sign in to unlock

Parties

Hygeia Chemicals Limited

Applicant/appellant

Irish Medicines Board

Respondent/respondents

Procedural Posture

Judicial Review Appeal / Supreme Court Appeal From High Court Judgment

  1. 1 Whether the procedures adopted by the Irish Medicines Board and/or its Advisory Committee denied the appellant a fair or proper hearing contrary to natural and constitutional justice.
  2. 2 Whether the decisions of the Advisory Committee and the Board were tainted by subjective or objective bias.
  3. 3 Whether the precautionary principle under Community Law required specific procedures which were not adopted or applied.

Ratio Decidendi

The Supreme Court held that the absence of clear by-laws or rules governing the review and appeal process, the lack of transparency regarding the applicable standards, and the imposition of restrictive time limits without adequate disclosure of relevant materials resulted in procedures that did not meet the requirements of constitutional justice and fair procedures. The process adopted by the Irish Medicines Board was found to be unfair and insufficient in law to justify the annulment of valuable property rights.

Court Disposition

Appeal allowed; High Court order set aside.

Orders

  • Order of certiorari quashing the decision of the Irish Medicines Board dated 26 February 2003.
  • Costs to the appellant.